{"product_id":"home-mechanical-ventilation-and-respiratory-care","title":"Home Mechanical Ventilation and Respiratory Care","description":"\u003cp\u003e\u003cstrong\u003e\u003cspan data-mce-fragment=\"1\"\u003eEverything you can learn about fluid and the latest development in research from the world's top scientsits. Streaming is available on request.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMore than 24 hours of content in english :\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003cstrong\u003e13th International Conference on Home Mechanical Ventilation \u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e4th European Respiratory Care Association Congress\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003eProgram :\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJIVD is 23 years old\u003cbr\u003e\u003cstrong\u003eD. Robert (Lyon, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eERCA : Who we are ?\u003cbr\u003e\u003cstrong\u003eP. Joud (Lyon, France)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eCriteria and benefits according to different diseases in adults\u003cbr\u003e\u003cstrong\u003eM. Elliott (Leeds, UK)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHow to define a well ventilated patient\u003cbr\u003e\u003cstrong\u003eC. Rabec (Dijon, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eThe causes and assessment of chronic respiratory failure in\u003cbr\u003echildren\u003cbr\u003e\u003cstrong\u003eC. Wallis (London, UK)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWhen to start : which benefits according to different diseases\u003cbr\u003e\u003cstrong\u003eA. Simonds (London, UK)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdate in the ventilators and interfaces available for young\u003cbr\u003echildren\u003cbr\u003e\u003cstrong\u003eB. Fauroux (Paris, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eLimits of LTMV in ALS\u003cbr\u003e\u003cstrong\u003eA. Pinto (Parede, PT)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMultidisciplinary ALS centers\u003cbr\u003e\u003cstrong\u003eJ. Gonzales (Paris, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eOHS in adults: a heterogeneous syndrome\u003cbr\u003e\u003cstrong\u003eJL Pepin (Grenoble, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTracheotomy\u003cbr\u003e\u003cstrong\u003eO. Jonquet (Montpellier, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eOHS in Children\u003cbr\u003e\u003cstrong\u003eR. Bhattacharjee (Chicago, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eModalities of Treatment\u003cbr\u003e\u003cstrong\u003eJ.C. Janssens (Geneva, CH)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdate on actual indications\u003cbr\u003e\u003cstrong\u003eD. Robert (Lyon, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eEarly Management\u003cbr\u003e\u003cstrong\u003eM-J Kampelmacher (Utrecht, NL)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDaily living for tracheostomised people\u003cbr\u003e\u003cstrong\u003eD. Orlikowski (Garches, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSleep related disturbances\u003cbr\u003e\u003cstrong\u003eP. Lévy (Grenoble, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eO2, PAP treatment modalities\u003cbr\u003e\u003cstrong\u003eS. Javaheri (Mason, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eFuture nedds for LTMV\u003cbr\u003e\u003cstrong\u003eP. Léger (Lyon, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eGuidelines according to different countries\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003eD.A. McKim (Ottawa, Canada)\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHow to start a new center for LTMV\u003cbr\u003e\u003cstrong\u003eJ. Escarrabill Sanglas (Barcelona, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTherapeutic education - Limits\u003cbr\u003e\u003cstrong\u003eC. Terral (Montpellier, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTherapeutic education - Experience\u003cbr\u003e\u003cstrong\u003eN. Ambrosino (Pisa, IT)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDefinition of palliative use\u003cbr\u003e\u003cstrong\u003eO. Jonquet (Montpellier, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003ePalliative use of NIV in Babies in Babies\u003cbr\u003e\u003cstrong\u003eB. Estournet (Garches, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eEnd of life and LTMV\u003cbr\u003e\u003cstrong\u003eM. Vitacca (Gussago, IT)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eCOPD heteregeneous disease\u003cbr\u003e\u003cstrong\u003eB. Make (Denver, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDecisions in ALS\u003cbr\u003e\u003cstrong\u003eP. Banfi (Milano, IT), E. Farrero (Barcelona, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eApnea in chronic respiratory insufficiency\u003cbr\u003e\u003cstrong\u003eJ. Verbraecken (Edegem, BE), P. De Lucas Ramos (Madrid, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNovel uses of NIV, \u003c\/div\u003e\n\u003cdiv\u003e\n\u003cstrong\u003eN. Hill (Boston, US), J. Benditt (Seattle, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHow to start elective LTMV\u003cbr\u003e\u003cstrong\u003eM. Chatwin (London, UK), P.J. Wijkstra (Groningen, NL)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAcute exacerbation of chronically ventilated patients\u003cbr\u003e\u003cstrong\u003eA. Cuvelier (Rouen, FR), N. Hill (Boston, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSide effects during LTMV\u003cbr\u003e\u003cstrong\u003eF. Stehling (Essen, DE), O. Norregaard (Arhus, DK)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNIV in COPD\u003cbr\u003e\u003cstrong\u003eW. Windisch (Köln, DE), E. Clini (Modena, IT)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTravelling\u003cbr\u003e\u003cstrong\u003eJ. Winck (Porto, PT), B. Gaudon (Lyon, FR)\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eO2 supplementation in rehabilitation and in LTMV\u003cbr\u003epatients\u003cbr\u003e\u003cstrong\u003eJ.C. Borel (Grenoble, FR), \u003c\/strong\u003eE. Clini (Modena, IT)\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eLT-Oxygen therapy versus LT-NIV in extra-pulmonary\u003cbr\u003erestrictive disorders\u003cbr\u003e\u003cstrong\u003eJ.C. Borel (Grenoble, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eE-Learning\u003cbr\u003e\u003cstrong\u003eR. Golstein (Toronto, CA), T. Marti (Barcelona, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdate on home ventilators and modes\u003cbr\u003e\u003cstrong\u003eR. Farré (Barcelona, ES), F. Lofaso (Garches, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSetting up of home and wheelchair for ventilated\u003cbr\u003eneuromuscular individuals\u003cbr\u003e\u003cstrong\u003eP. Soudon (Brussels, BE), I. Badoil (Lyon, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTelemonitoring\u003cbr\u003e\u003cstrong\u003eJ-F Muir (Rouen, FR), M. Vitacca (Gussago, IT)\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSleep and NIV\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cstrong\u003eD. Rodenstein (Brussels, BE), F. Masa (Caceres, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDiaphragmatic pacing\u003cbr\u003e\u003cstrong\u003eJ. Gonzalez-Bermejo (Paris, FR), R. Onders (Cleveland, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eFollow-up during LTMV\u003cbr\u003e\u003cstrong\u003eM. Gaytant (Utrecht, NL), L. Noël (Montréal, CND)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSwallowing disorders\u003cbr\u003e\u003cstrong\u003eN. Terzi (Caen, FR), L. Jacquin (Lyon, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTetraplegia : clinical cases\u003cbr\u003e\u003cstrong\u003eB. Estournet (Garches, FR), J. Viroslav (Dallas, US)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eCystic fibrosis and bronchiectasis\u003cbr\u003e\u003cstrong\u003eP-R Burgel (Paris, FR), F. Moran (Belfast, UK)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eVentilator Circuits and accessories\u003cbr\u003e\u003cstrong\u003eZ. Szkulmowski (Bydgoszcz, PL)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHumidification during long term mechanical venilation\u003cbr\u003e\u003cstrong\u003eZ. Szkulmowski (Bydgoszcz, PL)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHome polygraphy and Monitoring during LTMV\u003cbr\u003e\u003cstrong\u003eC. Perrin (Cannes, FR)\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eNIV in children\u003cbr\u003e\u003cstrong\u003eM. Pons (Barcelona, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eInterfaces for NIV\u003cbr\u003e\u003cstrong\u003eC. Gregoretti (Moncalieri, IT), G. Laier Groeneveld (Oberhausen, DE)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eClinical Cases: Cerebral Palsy and rare myopathies\u003cbr\u003e\u003cstrong\u003eM. Cols (Barcelona, SP), A. Vianello (Padova, IT)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTracheostomy removal\u003cbr\u003e\u003cstrong\u003eJ. Bach (Newark, US), M. Gonçalves (Porto, PT)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSpeaking during mechanical ventilation\u003cbr\u003e\u003cstrong\u003eD. Hess (Danvers, US), H. Prigent (Garches, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNIV and surgery in patients at risk\u003cbr\u003e\u003cstrong\u003eS. Jaber (Montpellier, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNIV and surgery in patients at risk\u003cbr\u003e\u003cstrong\u003eG. Laier Groeneveld (Oberhausen, DE)\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eSpecificity of elderly patients in ICU\u003cbr\u003e\u003cstrong\u003eM. Ferrer (Barcelona, SP)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNewborn: non invasive ventilation\u003cbr\u003e\u003cstrong\u003eG. Olguin (Buenos Aires, AR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAcute newborn bronchiolitis\u003cbr\u003e\u003cstrong\u003eB. Fauroux (Paris, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eEffects and Impact of NIV\u003cbr\u003e\u003cstrong\u003eM. Toussaint (Brussels, BE)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSecretion Management techniques\u003cbr\u003e\u003cstrong\u003eM. Chatwin (London, UK)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHome Respiratory Care\u003cbr\u003e\u003cstrong\u003eO. Fondenes (Bergen, NO)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNIV and pulmonary rehabilitation\u003cbr\u003e\u003cstrong\u003eW. Windisch (Köln, DE)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTraining post pulmonary rehabilitation\u003cbr\u003e\u003cstrong\u003eT. Troosters (Leuven, BE)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eProspective of a French working group - \u003cstrong\u003ePro-Con debate\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eB. Selleron (Orléans, FR)\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eProspective of a French working group - \u003cstrong\u003ePro-Con debate\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eJ. Bott (London, UK)\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/div\u003e","brand":"DVDCongress","offers":[{"title":"Default Title","offer_id":39846484377768,"sku":"","price":99.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0331\/9188\/6892\/products\/JIVD2012.png?v=1620314994","url":"https:\/\/e-onescience.org\/products\/home-mechanical-ventilation-and-respiratory-care","provider":"DVDCongress","version":"1.0","type":"link"}